Zusammenfassung
Osteoporose und Osteomalazie sind systemische metabolische Knochenerkrankungen, welche die Zusammensetzung, Architektur und Funktion des Knochens beeinträchtigen. Aufgrund der demografischen Entwicklung und sensitiver Nachweisverfahren werden beide Erkrankungen zunehmend häufiger diagnostiziert. Insbesondere ältere und chronisch kranke Menschen oder Bewohner in Seniorenresidenzen sind betroffen. Patienten mit gastroenterologischen, rheumatologischen und endokrinologischen Grunderkrankungen weisen ebenfalls ein hohes Risiko einer Osteoporose oder Osteomalazie auf. In dieser aktuellen Übersicht werden die praktischen Aspekte zur Klinik und Diagnostik der Osteoporose und der Osteomalazie dargestellt.
Abstract
Osteoporosis and osteomalacia are systemic metabolic bone diseases characterized by an impaired composition, architecture, and quality of bone. In light of the demographic development and the recent use of sensitive tests, both diseases are increasingly diagnosed. Subjects at high risk include elderly, chronically hospitalized patients, and nursing home residents. Patients with gastrointestinal, rheumatologic and endocrine disorders are also at risk for the development of osteoporosis or osteomalacia. In this review, we will discuss practical aspects of the clinical presentation and the diagnosis of osteoporosis and osteomalacia.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Allali F, El Aichaoui S, Saoud B et al. (2006) The impact of clothing style on bone mineral density among post menopausal women in Morocco: a case-control study. BMC Public Health 6: 135
Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis – pathophysiology and therapy. Osteoporos Int 18: 1319–1328
Ebeling PR (2008) Osteoporosis in men. N Engl J Med 358: 1474–1482
Fogelman I, Blake GM (2005) Bone densitometry – an update. Lancet 366: 2068–2070
Hadji P, Body JJ, Aapro MS et al. (2008) Practical guidance for the management of aromatase inhibitor-associated bone loss. Ann Oncol 19: 1407–1416
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266–281
Jakob F (2007) Metabolic bone diseases. Internist 48: 1101–1118
Kanis JA, Johnell O, Oden A et al. (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19: 385–397
Kann PH, Pfutzner A, Delling G et al. (2006) Transiliac bone biopsy in osteoporosis – frequency, indications, consequences and complications. An evaluation of 99 consecutive cases over a period of 14 years. Clin Rheumatol 25: 30–34
Pfeilschifter J (2006) DVO-guideline for prevention, diagnosis and therapy of osteoporosis for women after menopause, for men after age 60 executive summary guidelines. Exp Clin Endocrinol Diabetes 114: 611–622
Raisz LG (2005) Pathogenesis of osteoporosis – concepts, conflicts and prospects. J Clin Invest 115: 3318–3325
Raisz LG (2005) Screening for osteoporosis. N Engl J Med 353: 164–171
Rosen CJ (2005) Postmenopausal osteoporosis. N Engl J Med 353: 595–603
Seeman E, Delmas PD (2006) Bone quality – the material and structural basis of bone strength and fragility. N Engl J Med 354: 2250–2261
Tinetti ME (2003) Preventing falls in elderly persons. N Engl J Med 348: 42–49
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Därr, R., Ziller, V., Hadji, P. et al. Klinik und Diagnostik der Osteoporose und Osteomalazie. Internist 49, 1170–1177 (2008). https://doi.org/10.1007/s00108-008-2114-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-008-2114-z